Navigation Links
Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results
Date:5/23/2013

TARRYTOWN, N.Y., May 23, 2013 /PRNewswire/ -- Direct to implant, or "one step," breast reconstruction following mastectomy is an appropriate option for many women with BRCA (BReast CAncer) gene mutations seeking to surgically reduce their breast cancer risk, or with breast cancer. Traditionally, post-mastectomy reconstruction involves a gradual expansion process and a second surgery to insert permanent implants, but immediate placement of implants in the same surgery as mastectomy can be a medically and cosmetically effective alternative.

The direct to implant procedure provides an immediate breast reconstruction within one surgery, with a permanent implant placed in the breast immediately following breast tissue removal. A specially prepared skin tissue, or acellular dermal matrix (ADM), is positioned over the implant as a muscle extender to avoid the need for tissue expanders. Direct to implant breast reconstruction is often performed as part of a nipple sparing mastectomy.

" Angelina Jolie and other celebrities who have disclosed their breast cancer risk-reduction choices have helped open a public dialogue that benefits high-risk women facing similar decisions," said C. Andrew Salzberg, MD, of the New York Group for Plastic Surgery and associate professor at NY Medical College and Chief of Plastic Surgery at Westchester Medical Center, who pioneered the direct to implant breast reconstruction procedure using ADM more than a decade ago. "It's important that women are made aware of the range of surgical options available to them."

"Many women are eligible for direct to implant surgery, which provides excellent aesthetic results with reduced physical discomfort and time to final cosmetic results," said Dr. Salzberg. "We typically perform the entire direct to implant procedure in three hours, which is shorter than most other mastectomy and breast reconstruction surgeries and lessens time spent under anesthesia." He added that while some patients will require or opt for a follow-up revision procedure, most won't need further surgery after the initial procedure.

The traditional mastectomy and breast reconstruction procedure requires tissue expanders placed in the breast immediately after breast tissue removal. The expanders are filled with saline over three to six months to stretch the skin and muscle, and permanent implants are placed during a second surgery.

Direct to implant surgery allows a woman to wake from surgery with reconstructed breasts and no waiting time to completion, said Dr. Salzberg. He stressed, however, that the success of a direct to implant procedure requires appropriate patient selection and a comprehensive pre-surgery consultation to confirm that this surgical option is best for the individual woman and to review the risks and benefits.

"An ideal candidate for direct to implant, or one step, breast reconstruction has healthy breast skin that can stretch for the implant and doesn't have excessive sagging, known as ptosis," Dr. Salzberg said. "Also, for a very large breasted woman choosing prophylactic mastectomy, particularly if she wants to spare her nipples, we may first perform a breast reduction followed by a separate surgery for the mastectomy and direct to implant reconstruction."

Dr. Salzberg published his most recent peer-reviewed study on direct to implant mastectomy and breast reconstruction in the November 2012 issue of Plastic and Reconstructive Surgery, the journal of the American Society of Plastic Surgeons. It included women who had mastectomy and breast reconstruction for breast cancer or prophylactically (preventively) because of high genetic risk such as a BRCA mutation or strong family history of breast cancer. The procedure was shown to be safe and reliable with a low overall complication rate.

About Dr. Salzberg and the New York Group for Plastic Surgery

C. Andrew Salzberg , MD specializes in breast reconstruction and cosmetic procedures as a board certified surgeon with the New York Group for Plastic Surgery (NYGPS). He regularly performs direct to implant breast reconstruction on women from around the country who are undergoing mastectomy for cancer treatment or prevention. The New York Group for Plastic Surgery is comprised of highly trained plastic surgeons certified by the American Board of Plastic Surgery (ABPS) and recognized for their specialized medical and cosmetic surgical skills and personalized patient care. 

Contact:          
Andrea Ziltzer 
AZ Healthcare Communications                                                                                       
Andrea@AZHealthcomm.com 
914.923.3547

 


'/>"/>
SOURCE New York Group for Plastic Surgery
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Academy of Managed Care Pharmacy (AMCP) Installs 2012-2013 Board of Directors
2. Angeion Selects Hendrik Struik for Board of Directors
3. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
4. WAISMANN METHOD® Director Encourages Public to Participate in National Take-Back Day
5. SCOLR Pharma Welcomes Clem Calabrese as Director of Field Sales
6. Althea Technologies Appoints Dr. Kristin DeFife, Director, Biologics Manufacturing And Jack Wright, VP, Sales and Marketing
7. WAISMANN METHOD® Medical Director Voices Support for Fibromyalgia Awareness Day
8. Young Innovations, Inc. Board Of Directors Declares Quarterly Dividend
9. Allscripts Adds Two Independent Directors to Board
10. Accuray Appoints Richard Pettingill, LFACHE to Board of Directors
11. Gentech Pharmaceutical Appoints New Medical Director for PhenTabz/ADDTabz
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... and SAN DIEGO , ... Inc., a global leader in viral gene therapy manufacturing, ... treatments for congestive heart failure and other chronic diseases, ... a scalable manufacturing process and produce cGMP-grade RT-100 (Ad5.hAC6) ... --> --> ...
(Date:2/10/2016)... 2016 Immune Pharmaceuticals Inc. (NASDAQ: IMNP ... it has filed a patent application directed to the ... --> --> The new ... Ceplene (histamine dihydrochloride) in combination with immune checkpoint inhibitors. ... efficacy of Ceplene and IL-2 therapy in patients with ...
(Date:2/10/2016)... Feb. 10, 2016  Oxis International Inc. (OTC/QB: OXIS) ... was described as a "clinical trial triumph" after one ... into complete cancer remission. Daniel Vallera ... Masonic Cancer Center. --> Daniel Vallera ... Masonic Cancer Center. --> An article ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... February 10, 2016 , ... Ongoing news of the ravages of traumatic brain ... conduct a survey that takes a closer look at cases of TBI being managed ... causes of TBI among the aging population, and identifies the challenges associated with their ...
(Date:2/10/2016)... MI (PRWEB) , ... February 10, 2016 , ... ... Apifiny® across their network of laboratory service centers across the country. Launched ... to aid clinicians in the detection of prostate cancer. Apifiny order volume exceeded 3,000 ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... ... announced that it has been awarded the prestigious Distinguished Emerald Club of the ... program conducted by BoardRoom magazine, one of the most respected trade publications serving ...
(Date:2/10/2016)... ... February 10, 2016 , ... Workrite Ergonomics, who is celebrating ... evolved from humble beginnings to being an internationally recognized leader in their industry. , ... today”, said Charlie Lawrence, President of Workrite. “Workrite recognized the importance of good ...
(Date:2/10/2016)... ... February 09, 2016 , ... ... Face and Body Specialists are delighted to welcome a new addition to their ... Face and Body Specialists as a nurse practitioner performing cosmetic procedures ...
Breaking Medicine News(10 mins):